Rare Diseases in Cancer and Treatment

rare cancer might be a subtype of a most common cancer. Rare cancers include thyroid cancer, acute lymphoblastic leukemia (ALL) and mouth cancer. There are also many rare cancers most people will not be familiar with. Although the incidence of individual rare cancers is low, as a collective they represent nearly a quarter of all cancers, more than any single common cancer. Rare cancers have been divided into two groups: cancers defined by their unusual histogenesis (cell of origin or differentiation state) and histologically defined subtypes of common cancers. The presence of specific genetic variants provides rationale for the testing of targeted drugs in rare cancers and they represent roughly 20% of all human cancers and are associated with worse survival. Diagnosis of rare cancers may consume a lot of time and about one in five rare cancers affect the blood and lymphatic system. Rare cancers caused by simple genetic mutations and common cancers tend to be caused by a complex set of genetic and epigenetic aberrations that continually grow in number as the tumor develops. A cancer is considered to be rare.

 

  • Carcinoma
  • sarcoma
  • melanoma
  • lymphoma
  • Leukemia

Related Conference of Rare Diseases in Cancer and Treatment

May 10-11, 2021

4th Global Experts Meeting on Infectious Diseases

Singapore City, Singapore
May 27-28, 2021

7th Rare Diseases and Orphan Drugs

Vienna, Austria
July 19-20, 2021

13th Global Infections Conference

Tokyo, Japan
September 06-07, 2021

11th World Congress on Rare Diseases and Orphan Drugs

Berlin, Germany
October 21-22, 2021

International Conference on Tropical Diseases and Cure

Zurich, Switzerland
November 22-23, 2021

3rd World Congress on Advancements in Tuberculosis and Lung Diseases

Singapore City, Singapore
February 07-08, 2022

9th International Congress on Infectious Diseases

Aberdeen, UK

Rare Diseases in Cancer and Treatment Conference Speakers

Recommended Sessions

Related Journals

Are you interested in